Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia.

Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia.

Item
http://www.wikidata.org/entity/Q34509676
Current and novel antibiotics against resistant Gram-positive bacteriaOritavancin diphosphateOritavancin for acute bacterial skin and skin structure infections.Validation and Application of a Dried Blood Spot Ceftriaxone Assay.Antimicrobial therapy of Staphylococcus aureus bloodstream infection.Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.Oritavancin: a potential weapon in the battle against serious Gram-positive pathogens.Current challenges in treating MRSA: what are the options?Vancomycin resistance: are there better glycopeptides coming?Newer developments in the treatment of Gram-positive infections.Oritavancin: A Long-Half-Life Lipoglycopeptide.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin.Pharmacodynamics of teicoplanin against MRSA.
P2860

Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia.

Item
http://www.wikidata.org/entity/Q34509676
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@ast
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@en
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@nl
type
label
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@ast
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@en
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@nl
prefLabel
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@ast
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@en
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Pharmacokinetic-pharmacodynami ...... phylococcus aureus bacteremia.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.50.3.994-1000.2006
P407
P433
P478
P577
P698
P932